Bayesian analysis and classification of two enzyme‐linked immunosorbent assay tests without a gold standard
暂无分享,去创建一个
[1] D. Montefiori,et al. GB Virus Type C Envelope Protein E2 Elicits Antibodies That React with a Cellular Antigen on HIV-1 Particles and Neutralize Diverse HIV-1 Isolates , 2010, The Journal of Immunology.
[2] Ronald Christensen,et al. Bayesian Ideas and Data Analysis: An Introduction for Scientists and Statisticians , 2010 .
[3] R. Gascoyne,et al. GBV‐C/hepatitis G virus infection and non‐Hodgkin lymphoma: a case control study , 2010, International journal of cancer.
[4] J. McLinden,et al. Viruses within the Flaviviridae Decrease CD4 Expression and Inhibit HIV Replication in Human CD4+ Cells1 , 2009, The Journal of Immunology.
[5] J. Stapleton,et al. GB virus type C interactions with HIV: the role of envelope glycoproteins , 2009, Journal of viral hepatitis.
[6] K. Chaloner,et al. GBV-C viremia is associated with reduced CD4 expansion in HIV-infected people receiving HAART and interleukin-2 therapy , 2009, AIDS.
[7] Bruce W. Turnbull,et al. Nonparametric estimation of ROC curves based on Bayesian models when the true disease state is unknown , 2007 .
[8] M. Houghton,et al. Characterization of an Immunodominant Antigenic Site on GB Virus C Glycoprotein E2 That Is Involved in Cell Binding , 2006, Journal of Virology.
[9] Wesley O. Johnson,et al. Bayesian inferences for receiver operating characteristic curves in the absence of a gold standard , 2006 .
[10] K. Chaloner,et al. Effect of early and late GB virus C viraemia on survival of HIV‐infected individuals: a meta‐analysis , 2006, HIV medicine.
[11] M. Plummer,et al. CODA: convergence diagnosis and output analysis for MCMC , 2006 .
[12] P. Qiu. The Statistical Evaluation of Medical Tests for Classification and Prediction , 2005 .
[13] Xiao-Hua Zhou,et al. Nonparametric Estimation of ROC Curves in the Absence of a Gold Standard , 2005, Biometrics.
[14] J. Slim,et al. Prevalence of GB virus type C in urban Americans infected with human immunodeficiency virus type 1 , 2005, Retrovirology.
[15] Morris H. DeGroot,et al. Optimal Statistical Decisions: DeGroot/Statistical Decisions WCL , 2005 .
[16] Andrew Gelman,et al. R2WinBUGS: A Package for Running WinBUGS from R , 2005 .
[17] Xiao-Hua Zhou,et al. NONPARAMETRIC ESTIMATION OF COMPONENT DISTRIBUTIONS IN A MULTIVARIATE MIXTURE , 2003 .
[18] B. Craig,et al. Estimating disease prevalence in the absence of a gold standard , 2002, Statistics in medicine.
[19] S. Nielsen,et al. Maximum-likelihood estimation of sensitivity and specificity of ELISAs and faecal culture for diagnosis of paratuberculosis. , 2002, Preventive veterinary medicine.
[20] M. Manns,et al. Infection with GB virus C and reduced mortality among HIV-infected patients. , 2001, The New England journal of medicine.
[21] L. Joseph,et al. Bayesian Approaches to Modeling the Conditional Dependence Between Multiple Diagnostic Tests , 2001, Biometrics.
[22] Andrew Thomas,et al. WinBUGS - A Bayesian modelling framework: Concepts, structure, and extensibility , 2000, Stat. Comput..
[23] J. Lang,et al. High Prevalence of GB Virus C/Hepatitis G Virus RNA and Antibodies in Patients Infected with Human Immunodeficiency Virus Type 1 , 2000, European Journal of Clinical Microbiology and Infectious Diseases.
[24] W O Johnson,et al. Estimation of sensitivity and specificity of diagnostic tests and disease prevalence when the true disease state is unknown. , 2000, Preventive veterinary medicine.
[25] F. Lucht,et al. Prevalence of GBV‐C/hepatitis G virus RNA and E2 antibody among subjects infected with human immunodeficiency virus type 1 after parenteral or sexual exposure , 1999, Journal of medical virology.
[26] D. Ouzan,et al. High prevalence of GB virus C/hepatitis G virus infection in different risk groups of HIV-infected patients. , 1998, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[27] S. Hui,et al. Evaluation of diagnostic tests without gold standards , 1998, Statistical methods in medical research.
[28] M. Manns,et al. GB virus C/hepatitis G virus infection: a favorable prognostic factor in human immunodeficiency virus-infected patients? , 1998, The Journal of infectious diseases.
[29] I Yang,et al. Latent variable modeling of diagnostic accuracy. , 1997, Biometrics.
[30] K. Stark,et al. Detection of antibodies to a putative hepatitis G virus envelope protein , 1997, The Lancet.
[31] M. Tan,et al. Random effects models in latent class analysis for evaluating accuracy of diagnostic tests. , 1996, Biometrics.
[32] L. Joseph,et al. Bayesian estimation of disease prevalence and the parameters of diagnostic tests in the absence of a gold standard. , 1995, American journal of epidemiology.
[33] Jun S. Liu,et al. Linear Combinations of Multiple Diagnostic Markers , 1993 .
[34] Adrian E. Raftery,et al. [Practical Markov Chain Monte Carlo]: Comment: One Long Run with Diagnostics: Implementation Strategies for Markov Chain Monte Carlo , 1992 .
[35] M. Bronskill,et al. Receiver Operator characteristic (ROC) Analysis without Truth , 1990, Medical decision making : an international journal of the Society for Medical Decision Making.
[36] S D Walter,et al. Estimation of test error rates, disease prevalence and relative risk from misclassified data: a review. , 1988, Journal of clinical epidemiology.
[37] P M Vacek,et al. The effect of conditional dependence on the evaluation of diagnostic tests. , 1985, Biometrics.
[38] A. Azzalini. A class of distributions which includes the normal ones , 1985 .
[39] Philip Heidelberger,et al. Simulation Run Length Control in the Presence of an Initial Transient , 1983, Oper. Res..
[40] S. Walter,et al. Estimating the error rates of diagnostic tests. , 1980, Biometrics.
[41] M. Degroot. Optimal Statistical Decisions , 1970 .